Focus Partners Wealth Has $70.16 Million Stake in GE HealthCare Technologies Inc. $GEHC

Focus Partners Wealth raised its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.8% in the fourth quarter, Holdings Channel reports. The fund owned 855,594 shares of the company’s stock after acquiring an additional 31,381 shares during the period. Focus Partners Wealth’s holdings in GE HealthCare Technologies were worth $70,164,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its stake in GE HealthCare Technologies by 0.5% in the fourth quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock valued at $4,287,658,000 after acquiring an additional 267,058 shares during the period. Dodge & Cox raised its holdings in shares of GE HealthCare Technologies by 13.4% during the fourth quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock worth $2,559,945,000 after acquiring an additional 3,693,918 shares during the period. Capital Research Global Investors raised its holdings in shares of GE HealthCare Technologies by 1.6% during the fourth quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock worth $2,080,248,000 after acquiring an additional 389,796 shares during the period. State Street Corp raised its holdings in shares of GE HealthCare Technologies by 2.0% during the fourth quarter. State Street Corp now owns 20,049,677 shares of the company’s stock worth $1,644,475,000 after acquiring an additional 401,932 shares during the period. Finally, Geode Capital Management LLC raised its holdings in shares of GE HealthCare Technologies by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 12,112,503 shares of the company’s stock worth $989,673,000 after acquiring an additional 37,159 shares during the period. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ GEHC opened at $65.18 on Monday. The stock has a 50 day moving average price of $66.32 and a 200 day moving average price of $75.18. GE HealthCare Technologies Inc. has a 52 week low of $58.75 and a 52 week high of $89.77. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22. The stock has a market capitalization of $29.65 billion, a PE ratio of 15.59, a price-to-earnings-growth ratio of 1.47 and a beta of 0.74.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The company had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. During the same period last year, the company posted $1.01 earnings per share. The business’s revenue for the quarter was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Analysts predict that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on GEHC. Stifel Nicolaus set a $80.00 price objective on GE HealthCare Technologies in a research report on Wednesday, April 29th. Mizuho reduced their price objective on GE HealthCare Technologies from $90.00 to $80.00 in a research report on Thursday, April 30th. Argus reduced their price objective on GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating for the company in a research report on Tuesday, May 19th. Wall Street Zen cut GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, March 21st. Finally, HSBC reduced their price objective on GE HealthCare Technologies from $100.00 to $90.00 in a research report on Thursday, April 30th. Nine research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $80.21.

Insider Activity

In related news, CFO James Saccaro purchased 3,310 shares of GE HealthCare Technologies stock in a transaction that occurred on Friday, May 1st. The stock was purchased at an average cost of $60.60 per share, with a total value of $200,586.00. Following the completion of the transaction, the chief financial officer owned 87,471 shares of the company’s stock, valued at approximately $5,300,742.60. This trade represents a 3.93% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Kevin Lobo acquired 10,000 shares of the company’s stock in a transaction on Friday, May 22nd. The stock was acquired at an average price of $64.18 per share, for a total transaction of $641,800.00. Following the purchase, the director directly owned 14,363 shares of the company’s stock, valued at approximately $921,817.34. This trade represents a 229.20% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last ninety days, insiders acquired 21,847 shares of company stock valued at $1,361,355. Corporate insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.